[1]
A. A. Ali, “The Effect of Long Term use of Glibenclamide on Serum and Urinary Sodium and Potassium Level in Type 2 DM Patients”, Iraqi Journal of Pharmaceutical Sciences , vol. 19, no. 1, pp. 58–61, Mar. 2017, doi: 10.31351/vol19iss1pp58-61.